Gosset Bionovis General Information
Bionovis has established itself as a pioneer in Brazil for the production and commercialization of biological and biosimilar medicines. The company has impacted over one million lives and sold more than thirteen million medicines across Brazil. It operates at commercial scale with several products already serving patients through public health channels such as the Ministry of Health. Its pipeline includes monoclonal antibodies like infliximab for autoimmune diseases. The company continues to expand its portfolio via technology transfer partnerships with global pharmaceutical leaders. Clinical results are not detailed publicly but commercial supply to national health systems indicates regulatory approval for marketed products.
Contact Information
Brazil
Drug Pipeline
No pipeline data available
Key Partnerships
Janssen-Cilag (Infliximab), other undisclosed global pharma partners for technology transfers
Bionovis Funding
No funding data available